These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 25526927)
1. Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy. Wang Y; Wu A; Chen X; Zhang L; Lin Y; Sun S; Cai W; Zhang B; Kang Z; Qiu W; Hu X; Lu Z BMC Neurol; 2014 Dec; 14():246. PubMed ID: 25526927 [TBL] [Abstract][Full Text] [Related]
2. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder. Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648 [TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders]. Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501 [TBL] [Abstract][Full Text] [Related]
4. Spinal cord atrophy in neuromyelitis optica spectrum disorders. Wang Y; Wang Y; Tan S; Lu Z Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea. Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965 [TBL] [Abstract][Full Text] [Related]
7. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD. Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682 [TBL] [Abstract][Full Text] [Related]
9. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD. Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678 [TBL] [Abstract][Full Text] [Related]
10. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082 [TBL] [Abstract][Full Text] [Related]
11. Resolution of inflammation in neuromyelitis optica spectrum disorders. Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851 [TBL] [Abstract][Full Text] [Related]
12. Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders. Wang X; Yi H; Liu J; Li M; Mao ZF; Xu L; Peng FH J Neurol Sci; 2016 Jul; 366():3-7. PubMed ID: 27288767 [TBL] [Abstract][Full Text] [Related]
14. Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S Mult Scler; 2016 Sep; 22(10):1371-5. PubMed ID: 26552730 [TBL] [Abstract][Full Text] [Related]
15. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235 [TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients. Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H; Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036 [TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
18. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders. Hu H; You X; Ye J Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441 [TBL] [Abstract][Full Text] [Related]
19. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869 [TBL] [Abstract][Full Text] [Related]
20. Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder. Liang J; Liu J; Fan R; Chen Z; Chen X; Tong J; Chen Y; Peng F; Jiang Y Neuroimmunomodulation; 2019; 26(5):258-264. PubMed ID: 31655825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]